SCHEMBL7196650

SCHEMBL7196650

Nc1nc(C(N)C=O)cs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
NOS1 P29475 1/20 0.39
HSD17B10 Q99714 5/20 0.35
GABRA5 P31644 1/20 0.35
GABRB2 P47870 1/20 0.35
ALDH1A1 P00352 7/20 0.34
BACE1 P56817 1/20 0.33
RAB9A P51151 5/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 6/20 0.32
NPC1 O15118 5/20 0.32
CYP3A4 P08684 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GFER P55789 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27724787 0.82 SMN1; SMN2 (0.40) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL10403192 0.80 SMN1; SMN2 (0.39) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL10831884 0.78 HSD17B10 (0.38) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL10610329 0.74 GABRA5 (0.42) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL7196645 0.72 SMN1; SMN2 (0.39) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL14003554 0.71 GABRA5 (0.46) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL8112798 0.71 HSD17B10 (0.42) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL7192491 0.71 HSD17B10 (0.46) SMN1; SMN2NOS1HSD17B10GABRA5GABRB2
SCHEMBL1795530 0.70
SCHEMBL4258592 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566355-B1 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens HOFFMANN-LA ROCHE INC. 2003-05-20 US disclosed
US-5712268-A Compositions of tricyclic β-lactams and uses thereof HOFFMANN-LA ROCHE INC. (US) 1998-01-27 US disclosed
US-5698577-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 US disclosed
EP-0508234-B1 Beta-lactames HOFFMANN LA ROCHE (CH) 1996-07-24 EP disclosed
US-5510343-A BETA-LACTAMASE INHIBITOR HOFFMANN-LA ROCHE INC. (US) 1996-04-23 US disclosed
EP-0508234-A2 Beta-lactames F. HOFFMANN-LA ROCHE AG (CH) 1992-10-14 EP disclosed